SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

SSgA Active Trust - State Street SPDR S&P 500 ETF Trust

The SPDR S&P 500 ETF Trust is trending lower amid an unexpected jobs loss and rising unemployment, compounded by escalating geopolitical tensions driving oil prices higher. The community is actively debating the potential for stagflation and anticipating further downside, with many bears calling for a significant market correction.

Indonesia Energy Corp. Ltd. operates as an oil and gas, exploration, and production company. It engages in oil and gas assets portfolio with a mix between medium-sized producing blocks and exploration blocks with significant resources. Its portfolio includes Kruh, Citarum, and Rangkas Area. The company was founded by James J. Huang and Wirawan Jusuf in 2014 and is headquartered in Jakarta, Indonesia.

Indonesia Energy Corp Ltd

Indonesia Energy Corp Ltd (INDO) is trending amid intensifying Middle East conflict and surging crude oil prices, fueling community discussions of an imminent short squeeze and expectations for the stock to mirror its past explosive movements during global energy supply disruptions.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is trending as escalating geopolitical tensions in the Middle East and concerns over the current administration's economic policies fuel community discussions about rising oil prices, job impacts, and high-profile leadership changes.

Invesco QQQ Trust Series 1 - Invesco QQQ Trust Series 1

QQQ is seeing intense selling pressure as a surprisingly weak jobs report fuels recession fears, while escalating Middle East tensions drive oil prices higher and ignite inflation concerns. The community is sharply divided between those predicting further declines and persistent dip-buyers banking on a swift market rebound despite the volatile backdrop.

Day One Biopharmaceuticals, Inc. operates as a holding company. The firm, through its subsidiary, develops and commercializes targeted therapies for patients of all ages with genetically defined cancers. Its products include DAY101 and pimsertib. The company was founded by Julie Grant and Samuel C. Blackman in November 2018 and is headquartered in Brisbane, CA.

Day One Biopharmaceuticals Inc

The acquisition of Day One Biopharmaceuticals by Servier for $2.5 billion, or $21.50 per share, is driving conversation as shareholders celebrate the significant premium and trapped shorts. This deal strengthens Servier's rare oncology portfolio and has the biotech community actively speculating on the next M&A target.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund (USO) is experiencing a notable surge, driven by escalating Middle East conflict and acute concerns over oil supply disruptions in the vital Strait of Hormuz. Community sentiment is deeply divided between those anticipating further gains from a significant 'war risk premium' and others forecasting a swift reversal due to potential political intervention aimed at stabilizing prices.

Marvell Technology, Inc. engages in the design, development, and sale of integrated circuits. Its products include data processing units, security solutions, automotive, coherent DSP, DCI optical modules, ethernet controllers, ethernet PHYs, ethernet switches, linear driver, PAM DSP, transimpedance amplifiers, fibre channel, HDD, SSD controller, storage accelerators, ASIC, and Marvell government solutions. It operates through the following geographical segments: United States, Singapore, Israel, India, China, and Others. The company was founded by Wei Li Dai and Pantas Sutardja in 1995 and is headquartered in Wilmington, DE.

Marvell Technology Inc

Marvell Technology is experiencing a significant surge following strong earnings, an upbeat outlook for the current quarter, and substantially raised multi-year revenue guidance driven by accelerating AI data center demand and leadership in optical connectivity. The community is actively discussing its strengthening position as a core AI infrastructure beneficiary, with multiple analyst upgrades reinforcing its growth potential.

ASP Isotopes, Inc. is a pre-commercial stage advanced materials company, which engages in the development of technology and processes that will allow for the enrichment of natural isotopes into higher concentration products. Its products include medical, green energy, and Industrial isotopes. The company was founded by Paul E. Mann and Robert Ainscow on September 13, 2021 and is headquartered in Dallas, TX.

ASP Isotopes Inc

ASPI is trending as its Quantum Leap Energy (QLE) subsidiary advances strategic collaborations with South Africa's Necsa for High Assay Low Enriched Uranium (HALEU) production and explores a U.S. partnership to bolster the domestic nuclear fuel supply chain. The community is focused on the anticipated QLE spin-off and recent institutional buying, though concerns persist regarding the timing of revenue from core isotope products and the stock's volatility within the wider nuclear sector.

ProShares Trust - ProShares Ultra VIX Short-Term Futures ETF 1.5x Shares

ProShares Ultra VIX Short-Term Futures ETF

ProShares Ultra VIX Short-Term Futures ETF ($UVXY) is trending as escalating geopolitical tensions, particularly regarding a potential conflict with Iran, drive significant market uncertainty and VIX spikes. Community members are actively debating whether to short its inherent decay on bounces or go long in anticipation of further volatility and a broader market downturn.

SoFi Technologies, Inc. is a financial service platform, which engages in the provision of student loan refinancing options to the private student loan market. It operates through the following segments: Lending, Technology Platform, and Financial Services. The Lending segment offers personal loans, student loans, home loan products, and related servicing activities. The Technology Platform segment focuses on technology products and solutions revenue. The Financial Services segment includes the SoFi Money product, SoFi Invest product, SoFi Credit Card product, SoFi Relay personal finance management product, and other financial services such as lead generation and content for other financial services institutions. The company was founded in 2011 and is headquartered in San Francisco, CA.

SoFi Technologies Inc

SoFi is trending amid high anticipation for a potential S&P 500 inclusion announcement, boosted by a new Mastercard stablecoin partnership and recent insider share purchases by its CEO. However, community sentiment remains divided, with optimism for long-term fintech growth tempered by historical volatility and concerns over market manipulation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Insider Buying: Promis Neurosciences (NASDAQ:PMN) Director Buys 1,000 Shares of Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams purchased 1,000 shares of the firm's stock in a transaction on Monday, March 2nd. The stock was bought at an average cost...

Eugene Williams Acquires 1,000 Shares of Promis Neurosciences (NASDAQ:PMN) Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams bought 1,000 shares of the company's stock in a transaction dated Monday, March 2nd. The stock was purchased at an average...

Promis Neurosciences (NASDAQ:PMN) Director Eugene Williams Buys 2,000 Shares

Promis Neurosciences (NASDAQ:PMN - Get Free Report) Director Eugene Williams purchased 2,000 shares of the company's stock in a transaction that occurred on Wednesday, March 4th. The shares were...

Promis Neurosciences (NASDAQ:PMN) Insider Buys $25,005.15 in Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) insider Johanne Kaplan bought 1,629 shares of Promis Neurosciences stock in a transaction on Thursday, February 19th. The shares were purchased at...

Insider Buying: Promis Neurosciences (NASDAQ:PMN) Major Shareholder Acquires 700,741 Shares of Stock

Promis Neurosciences (NASDAQ:PMN - Get Free Report) major shareholder Abg Management Ltd. bought 700,741 shares of the company's stock in a transaction that occurred on Tuesday, February 3rd. The...

ProMIS Neurosciences Secures $175 Mln In Private Financing

(RTTNews) - ProMIS Neurosciences Inc. (PMN), a clinical-stage biotechnology company, has announced on Friday a private investment in public equity financing of up to approximately $175 million...

ProMIS Neurosciences, Inc. engages in the discovery and development of precision medicine solutions for early detection and effective treatment of neurodegenerative diseases. It focuses on the progression of Alzheimer's disease, amyotrophic lateral sclerosis, and Parkinson's disease. The company was founded by Neil Cashman and Vigen Nazarian on January 23, 2004 and is headquartered in Toronto, Canada.

ProMIS Neurosciences Inc.

Software / SaaS

Cybersecurity

Cloud Infrastructure

AI / Semiconductors

Which beaten-down sector are you buying first?

Stocktwits

Stocktwits Polls

ProMIS Neurosciences

Traders are keenly watching for anticipated Phase 1b interim results in Q2 2026 for PMN310, especially given CEO remarks hinting at strong efficacy even at lower doses and no ARIA.

Heavy insider purchases, including significant buys by the Chairman, are fueling optimism, signaling strong internal conviction in the company's prospects.

Despite a current market cap around $50 million, many believe the company is significantly undervalued given its unique Alzheimer's therapy targets a potential $100 billion market.

PMN
ProMIS Neurosciences

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest PMN News

PMNProMIS Neurosciences